JPMORGAN CHASE & CO - GENOMIC HEALTH INC ownership

GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 127 filers reported holding GENOMIC HEALTH INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of GENOMIC HEALTH INC
ValueSharesWeighting
Q3 2019$18,215,000
+1400.4%
268,585
+1146.7%
0.00%
Q2 2019$1,214,000
-85.9%
21,543
-82.5%
0.00%
-100.0%
Q1 2019$8,605,000
+1746.6%
122,831
+1598.7%
0.00%
Q4 2018$466,000
+7.9%
7,231
+17.7%
0.00%
Q3 2018$432,000
+60.6%
6,145
+15.2%
0.00%
Q2 2018$269,000
+58.2%
5,332
-1.5%
0.00%
Q1 2018$170,000
-10.1%
5,415
-2.0%
0.00%
Q4 2017$189,000
+472.7%
5,524
+426.6%
0.00%
Q3 2017$33,000
+6.5%
1,049
+8.3%
0.00%
Q2 2017$31,000
+6.9%
969
+7.4%
0.00%
Q1 2017$29,000
+11.5%
902
+5.1%
0.00%
Q4 2016$26,000
+85.7%
858
+71.6%
0.00%
Q3 2016$14,000
-98.6%
500
-98.7%
0.00%
Q2 2016$970,000
+36.8%
37,472
+30.9%
0.00%
Q1 2016$709,000
-37.8%
28,629
-11.6%
0.00%
Q4 2015$1,140,000
+60.1%
32,397
-3.8%
0.00%
Q3 2015$712,000
-87.4%
33,666
-83.5%
0.00%
-100.0%
Q2 2015$5,665,000
+7.4%
203,870
+18.1%
0.00%0.0%
Q1 2015$5,273,000
+37.1%
172,591
+43.5%
0.00%0.0%
Q4 2014$3,845,000
+1144.3%
120,275
+1089.0%
0.00%
Q3 2013$309,000
-43.4%
10,116
-41.2%
0.00%
Q2 2013$546,00017,2030.00%
Other shareholders
GENOMIC HEALTH INC shareholders Q1 2016
NameSharesValueWeighting ↓
Camber Capital Management LP 2,150,000$68,736,0004.57%
Baker Brothers Advisors 13,656,318$436,592,0004.46%
NORTH TIDE CAPITAL, LLC 1,500,000$47,955,0003.22%
Motley Fool Wealth Management, LLC 72,732$2,325,0001.36%
Tributary Capital Management, LLC 150,896$4,824,0000.82%
Champlain Investment Partners, LLC 1,217,175$38,913,0000.62%
Motley Fool Asset Management LLC 71,935$2,300,0000.43%
IRONBRIDGE CAPITAL MANAGEMENT LP 440,410$14,080,0000.39%
CATAPULT CAPITAL MANAGEMENT LLC 35,000$1,119,0000.28%
Spark Investment Management LLC 51,100$1,633,0000.27%
View complete list of GENOMIC HEALTH INC shareholders